June Takeda

2.0k total citations
19 papers, 215 citations indexed

About

June Takeda is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, June Takeda has authored 19 papers receiving a total of 215 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 7 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in June Takeda's work include Acute Myeloid Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Hematopoietic Stem Cell Transplantation (3 papers). June Takeda is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Hematopoietic Stem Cell Transplantation (3 papers). June Takeda collaborates with scholars based in Japan, Sweden and United States. June Takeda's co-authors include N Yamada, Kazuhiko Maeda, Toshio Miyata, Takayoshi Kinoshita, Taroh Kinoshita, Wanchai Wanachiwanawin, Patcharin Pramoonjago, Shuichi Ota, Kazunari Aoki and Yukiyasu Ozawa and has published in prestigious journals such as Nucleic Acids Research, Blood and Diabetologia.

In The Last Decade

June Takeda

17 papers receiving 210 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
June Takeda Japan 6 120 110 50 47 32 19 215
Arnel Pallera United States 5 87 0.7× 105 1.0× 47 0.9× 50 1.1× 8 0.3× 7 160
Maria Antonietta Villa Italy 9 189 1.6× 68 0.6× 61 1.2× 10 0.2× 19 0.6× 19 245
Maria Gozzer Italy 9 133 1.1× 85 0.8× 34 0.7× 9 0.2× 13 0.4× 23 219
Fabiana Cacace Italy 4 117 1.0× 148 1.3× 69 1.4× 86 1.8× 9 0.3× 11 218
S. A. Wang United States 6 191 1.6× 128 1.2× 68 1.4× 28 0.6× 69 2.2× 7 267
Federica Portale Italy 6 23 0.2× 71 0.6× 34 0.7× 50 1.1× 50 1.6× 7 180
Juliette Soret France 6 77 0.6× 98 0.9× 77 1.5× 57 1.2× 26 0.8× 17 156
Helen Marr United Kingdom 10 32 0.3× 43 0.4× 64 1.3× 12 0.3× 64 2.0× 18 188
Louis Williams United States 9 110 0.9× 29 0.3× 22 0.4× 8 0.2× 84 2.6× 44 185
Peter W. Collins United Kingdom 5 87 0.7× 39 0.4× 20 0.4× 7 0.1× 27 0.8× 6 154

Countries citing papers authored by June Takeda

Since Specialization
Citations

This map shows the geographic impact of June Takeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by June Takeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites June Takeda more than expected).

Fields of papers citing papers by June Takeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by June Takeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by June Takeda. The network helps show where June Takeda may publish in the future.

Co-authorship network of co-authors of June Takeda

This figure shows the co-authorship network connecting the top 25 collaborators of June Takeda. A scholar is included among the top collaborators of June Takeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with June Takeda. June Takeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Nakagawa, Masaru, Yutaka Kuroda, Yasuhito Nannya, et al.. (2024). DISTINCT PATHOGENESIS OF CLONAL HEMATOPOIESIS REVEALED BY SINGLE-CELL MULTI-OMICS SEQUENCING.. Leukemia Research Reports. 21. 100435–100435. 1 indexed citations
2.
Tanaka, Yasuhiro, et al.. (2024). Pathogenic <i>TNFRSF13B</i> Variant in an Adult Japanese Patient with Common Variable Immunodeficiency. Internal Medicine. 64(5). 753–757.
3.
Takeda, June. (2022). [Molecular pathogenesis and therapeutic targets in acute erythroid leukemia].. PubMed. 63(2). 121–133. 1 indexed citations
4.
Morishita, Daisuke, Yotaro Ochi, Akio Mizutani, et al.. (2022). CTX-712, a Novel Splicing Modulator Targeting Myeloid Neoplasms. Blood. 140(Supplement 1). 489–490. 1 indexed citations
5.
Nakagawa, Masahiro, Yutaka Kuroda, Yasuhito Nannya, et al.. (2022). Distinct Pathogenesis of Clonal Hematopoiesis Revealed By Single Cell RNA Sequencing Integrated with Highly Sensitive Genotyping Method. Blood. 140(Supplement 1). 2881–2882. 1 indexed citations
6.
Morishita, Daisuke, Yotaro Ochi, Akio Mizutani, et al.. (2021). CTX-712, a Novel Clk Inhibitor Targeting Myeloid Neoplasms with SRSF2 Mutation. Blood. 138(Supplement 1). 205–205. 4 indexed citations
7.
Nakagawa, Masahiro, Yutaka Kuroda, Yasuhito Nannya, et al.. (2020). Distinct Pathogenesis of Clonal Hematopoiesis Revealed By Single Cell RNA Sequencing Integrated with Highly Sensitive Genotyping Method. Blood. 136(Supplement 1). 34–34. 1 indexed citations
8.
Polprasert, Chantana, June Takeda, Pimjai Niparuck, et al.. (2019). Novel DDX41 variants in Thai patients with myeloid neoplasms. International Journal of Hematology. 111(2). 241–246. 18 indexed citations
9.
Ishiyama, Ken, June Takeda, Naoshi Sugimoto, et al.. (2016). Feasibility of salvage cord blood transplantation following fludarabine, melphalan and low-dose TBI for graft rejection after hematopoietic stem cell transplantation. Bone Marrow Transplantation. 51(7). 985–987. 2 indexed citations
10.
Takeda, June, Kenichi Chiba, Yuichi Shiraishi, et al.. (2016). Genetic Profile of Acute Erythroid Leukemia. Blood. 128(22). 40–40. 2 indexed citations
11.
Arai, Yasuyuki, Kazunari Aoki, June Takeda, et al.. (2015). Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy. Journal of Hematology & Oncology. 8(1). 102–102. 26 indexed citations
12.
Arai, Yasuyuki, June Takeda, Kazunari Aoki, et al.. (2015). Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy. Blood. 126(3). 415–422. 43 indexed citations
13.
Yamauchi, Nobuhiko, Yasuhiro Kazuma, June Takeda, et al.. (2013). M-Protein Is Associated With Aggressive Disease In Patients With MALT Lymphoma. Blood. 122(21). 3008–3008.
15.
Tabata, Sumie, Masayuki Kurata, June Takeda, et al.. (2012). [Fatal hepatic failure due to AL amyloidosis in a patient with multiple myeloma].. PubMed. 53(11). 1906–10. 3 indexed citations
16.
Pramoonjago, Patcharin, et al.. (1995). Somatic mutations of PIG-A in Thai patients with paroxysmal nocturnal hemoglobinuria. Blood. 86(5). 1736–1739. 32 indexed citations
17.
Yamada, N, et al.. (1995). Somatic mutations of the PIG-A gene found in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood. 85(4). 885–892. 62 indexed citations
18.
Takeda, June, Yutaka Seino, Hirofumi Fukumoto, et al.. (1986). PvuII polymorphic sites in the human insulin receptor gene INSR. Nucleic Acids Research. 14(16). 6777–6777. 1 indexed citations
19.
Takeda, June, Y Yoshimasa, Hirofumi Fukumoto, et al.. (1986). Restriction fragment length polymorphism (RFLP) of the human insulin receptor gene in Japanese: its possible usefulness as a genetic marker. Diabetologia. 29(9). 667–669. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026